Showing results (741-750 of 778) with videos related to

Sort By:
Pageof 78
JAMA|May 17, 2022
Effect of Oral Methylprednisolone on Decline in Kidney Function or Kidney Failure in Patients With IgA Nephropathy: The TESTING Randomized Clinical TrialJicheng Lv, Muh Geot Wong, Michelle A Hladunewich, et al.
Kidney International|August 22, 2024
An expert discussion on the atypical hemolytic uremic syndrome nomenclature-identifying a road map to precision: a report of a National Kidney Foundation Working GroupCarla M Nester, David L Feldman, Richard Burwick, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 21, 2024
C3d-Targeted factor H inhibits tissue complement in disease models and reduces glomerular injury without affecting circulating complementFei Liu, Sarah T Ryan, Kelly C Fahnoe, et al.
Clinical Journal of the American Society of Nephrology : CJASN|June 3, 2024
Developing Therapies for C3 Glomerulopathy: Report of the Kidney Health Initiative C3 Glomerulopathy Trial Endpoints Work GroupCarla Nester, Dima A Decker, Matthias Meier, et al.
Nature Medicine|June 17, 2023
A meta-analysis of GFR slope as a surrogate endpoint for kidney failureLesley A Inker, Willem Collier, Tom Greene, et al.
Kidney International|October 11, 2025
Hierarchical clustering uncovered disease patterns and further untangled complexities in immune complex-mediated idiopathic MPGN and C3 glomerulopathyAriela Benigni, Erica Daina, Henry Löffler-Wirth, et al.
Orphanet Journal of Rare Diseases|June 3, 2021
The European Rare Kidney Disease Registry (ERKReg): objectives, design and initial resultsGiulia Bassanese, Tanja Wlodkowski, Aude Servais, et al.
Kidney International|December 8, 2022
Glomerular diseases in pregnancy: pragmatic recommendations for clinical managementFadi Fakhouri, Nora Schwotzer, Gianfranca Cabiddu, et al.
The New England Journal of Medicine|December 3, 2025
Trial of Pegcetacoplan in C3 Glomerulopathy and Immune-Complex MPGNFadi Fakhouri, Andrew S Bomback, Gema Ariceta, et al.
Clinical Journal of the American Society of Nephrology : CJASN|March 30, 2021
Ramipril and Cardiovascular Outcomes in Patients on Maintenance Hemodialysis: The ARCADIA Multicenter Randomized Controlled TrialPiero Ruggenenti, Manuel Alfredo Podestà, Matias Trillini, et al.
Pageof 78